Lung Transplant Program

Embark on a journey of innovation and discovery as we explore the latest advancements and emerging technologies in lung transplantation, offering new possibilities for personalized medicine, organ preservation, and immune tolerance induction to enhance transplant outcomes and improve patient care globally.

• Ex Vivo Lung Perfusion: Pulmonary transplant researchers investigate ex vivo lung perfusion techniques to preserve donor lungs, assess organ viability, and optimize organ function before transplantation, offering opportunities to expand the donor pool and reduce transplant wait times for patients in need of lung transplantation.
• Regenerative Therapies: Pulmonary scientists explore regenerative medicine approaches to lung repair and alveolar regeneration, utilizing stem cells, growth factors, and tissue engineering strategies to promote lung tissue healing, enhance alveolar function, and improve outcomes for patients with end-stage lung disease.
• Immune Tolerance Induction: Transplant immunologists and pulmonologists investigate immune tolerance induction strategies to minimize the need for long-term immunosuppression post-transplant, utilizing novel immunomodulatory agents, regulatory T cells, and donor-specific tolerance protocols to achieve transplant tolerance and improve graft acceptance rates while reducing medication-related complications for lung transplant recipients.
• Clinical Trials and Outcomes Research: Pulmonary transplant investigators conduct clinical trials and outcomes research to evaluate novel treatment strategies, immunosuppressive protocols, and patient management strategies in lung transplantation, offering patients access to cutting-edge therapies, innovative devices, and promising therapeutic approaches beyond standard of care options, contributing to advancements in lung transplant research, treatment optimization, and quality improvement initiatives to transform the future of pulmonary medicine and improve patient outcomes globally.